MiRNAs are small, noncoding RNAs, which can regulate gene expression
posttranscriptionally, and they have emerged as key factors in disease biology by aiding in …

Early diagnostic is one of the most important steps in cancer therapy which helps to design
and choose a better therapeutic approach. The finding of biomarkers in various levels …

Acute myeloid leukemias (AML) are clonal disorders of hematopoietic progenitor cells which
are characterized by relevant heterogeneity in terms of phenotypic, genotypic, and clinical …

Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), represent a family of RNA
molecules that do not translate into protein. Nevertheless, they have the ability to regulate …

Hepatocellular carcinoma (HCC) is a major malignant tumor type with a high incidence and
mortality. Infection with hepatitis virus is a high‑risk factor. Previous studies have …

The past decade has witnessed enormous progress, and has seen the noncoding RNAs
(ncRNAs) turn from the so-called dark matter RNA to critical functional molecules …

MicroRNAs (miRNAs) are regarded as promising cancer-related biomarkers. Here, we
developed a simple, sensitive and specific fluorescence method based on the combination …

Since their discovery in 1993, numerous microRNAs (miRNAs) have been identified in
humans and other eukaryotic organisms, and their role as key regulators of gene expression …

Since the breakthrough discovery of catalytic RNAs (ribozymes) in the early 1980s, valuable
ribozyme‐based gene therapies have been developed for incurable diseases ranging from …

Background Recent studies have shown that microRNA-155 (miR-155) is correlated with
clinical outcomes of leukemia. This meta-analysis explores to evaluate the prognostic value …